Delivery Order SPE2DB20D3104-SPE2DB23FV7G3
Award Date 6/12/23
Potential Completion Date 6/13/23
Potential Value $1.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Atomoxetine HCL 40 mg capsules to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 30, 2022 with a ceiling value of $2,114.66. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of March 31, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award, valued at $1,699.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of Atomoxetine HCL 40 mg capsules. The contract has a completion date of February 13, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award, solicitation number SPE2DB20D1004|SPE2DB24FF1R7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,992.79 firm fixed-price delivery order is for the supply of 80 mg Atomoxetine HCL capsules. The contract has an ultimate completion date of January 8, 2024 and was awarded on January 5, 2024. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Atomoxetine HCL 18 mg capsules. The award, with a ceiling value of $1,265.40, is structured as a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a maximum value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
- This federal contract award is for the delivery of Atomoxetine HCL 80 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical, which is a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a firm fixed-price delivery order with a ceiling value of $3,287.50 and an ultimate completion date of September 19, 2023....
- This federal contract award, with ID SPE2DB20D3104 and SPE2DB24FV5L3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,858.04 fixed-price delivery order is for the supply of 4563940986 - Atomoxetine HCL 40 mg capsules, with a completion date of March 13, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract...
- This federal contract award is for the delivery of Atomoxetine HCL 25 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The $1,008.04 firm-fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Atomoxetine HCL 60 mg capsules. The contract has a ceiling value of $1,069.76 and a performance period ending on December 12, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, identified as SPE2DB20D3103|SPE2DB24FP3H1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of atomoxetine hydrochloride 40 mg capsules in quantities of 30s. The contract is a firm-fixed-price delivery order with a ceiling value of $1,938.68 and an ultimate completion date of June 27, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 18 mg capsules of the drug Atomoxetine HCL, with a ceiling value of $1,180.72 and a completion date of April 9, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor, and there are no major...